REGENXBIO director granted RSUs and options
REGENXBIO Inc. director David C. Stump reported equity compensation awards, not open-market purchases.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
REGENXBIO Inc. director David C. Stump reported equity compensation awards, not open-market purchases. He received 9,807 shares of common stock underlying a time-based restricted stock unit that will vest on May 29, 2027, subject to his continuous service to the company.
He was also granted stock options covering 46,600 shares of common stock at an exercise price of $7.01 per share, which vest on May 29, 2027 and expire on May 29, 2036. Following these awards, he holds 28,861 shares of common stock directly.
Insider Trade Summary
Grant/Award: 56,407 shares
Grant/Award
2 txns
Insider
STUMP DAVID C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 46,600 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 9,807 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 46,600 contracts (Direct);
Common Stock — 28,861 shares (Direct)
Footnotes (2)
- F1. Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer.
- F2. The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer.
Key Figures
RSU shares granted: 9,807 shares
RSU vesting date: May 29, 2027
Options granted: 46,600 shares
+4 more
7 metrics
RSU shares granted
9,807 shares
Common stock underlying time-based RSU award granted May 29, 2026
RSU vesting date
May 29, 2027
100% of RSU shares vest on this date, subject to service
Options granted
46,600 shares
Stock options (right to buy) granted May 29, 2026
Option exercise price
$7.01 per share
Conversion or exercise price for the stock options
Option vesting date
May 29, 2027
Options vest on this date, subject to continuous service
Option expiration
May 29, 2036
Expiration date if options are not exercised earlier
Shares owned after awards
28,861 shares
Total direct common stock holdings following reported transactions
Key Terms
restricted stock unit, Stock Options (Right to Buy), exercise price, continuous service, +1 more
5 terms
restricted stock unit financial
"Represents shares of common stock underlying a time-based restricted stock unit award (RSU)."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Options (Right to Buy) financial
"Stock Options (Right to Buy) with 46,600.0000 shares and a $7.0100 exercise price."
exercise price financial
"conversion_or_exercise_price: "7.0100" for the stock options grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
continuous service financial
"will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer."
expiration date financial
"expiration_date: "2036-05-29T00:00:00.000Z" for the stock options."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did REGENXBIO (RGNX) director David C. Stump receive?
David C. Stump received 9,807 shares of common stock underlying a restricted stock unit and stock options for 46,600 shares at a $7.01 exercise price. Both awards were granted as equity compensation rather than open-market purchases.
When do David C. Stump’s new REGENXBIO (RGNX) RSUs vest?
The 9,807 restricted stock unit shares will vest on May 29, 2027, provided Stump maintains continuous service with REGENXBIO. Vesting means the shares become fully earned and transferable, turning the RSU award into actual common stock ownership at that date.
What are the key terms of David C. Stump’s REGENXBIO (RGNX) stock options?
Stump’s stock options cover 46,600 shares of common stock with a $7.01 exercise price. The options vest on May 29, 2027, contingent on continuous service, and expire on May 29, 2036 if not exercised before that expiration date.
Were David C. Stump’s REGENXBIO (RGNX) awards open-market stock purchases?
No. The filing describes the transactions as equity grants, including restricted stock units and stock options, with a transaction price per share of $0.00. These represent compensation awards from the company rather than shares bought on the open market.
What conditions apply to David C. Stump’s new REGENXBIO (RGNX) equity awards?
Both the RSU award and the stock options vest on May 29, 2027, subject to Stump’s continuous service to REGENXBIO. If continuous service conditions are not met, the awards may not fully vest according to the terms described in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates